Observational Study of Rapid Sequence Intubation (RSI) Drug Delivery Using Intraosseous (IO) and Intravenous (IV) Access in Pediatric Patients

Vidacare

Status: Withdrawn

Conditions: Airway Control

Study type: Observational

Funder types: Industry

Identifiers

NCT01634867

2012-03

Details and patient eligibility

About

This study will evaluate using intraosseous vascular access and intravenous vascular access to give pediatric patients the necessary medications to perform rapid sequence intubation, for patients with airway difficulties.

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• subjects requiring rapid sequence intubation for whom rocuronium is chosen as the paralytic agent.
• the operator chooses to place a peripheral intravenous or powered intraosseous catheter to permit rapid sequence intubation.

Exclusion criteria

• subjects in whom vascular access for rapid sequence intubation drug administration was established prior to arrival to the emergency department.

Trial design

0 participants in 2 patient groups

Intraosseous (IO) drug delivery

Description:

patients in whom intraosseous (IO) vascular access has been established for rapid sequence intubation drug delivery.

Peripheral intravenous (IV) drug delivery

Description:

patients in whom peripheral intravenous (IV) vascular access has been established for rapid sequence intubation drug delivery.